Annals of Oncology and Journal of Clinical Oncology Publish Group Study Results
The Annals of Oncology journal reports the results of the GEICAM / 9401 study on concomitant or sequential hormonal therapy with adjuvant chemotherapy.
C. Pico et al. Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered
concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast
cancer patients. A GEICAM 9401 study
Journal of Clinical Oncology publishes study GEICAM / 9903, which compares two chemotherapies (doxorubicin and docetaxel) administered simultaneously or sequentially, in metastatic breast cancer in the first line of treatment.
E. Alba et al. Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of
Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast
Cancer
Research Group (GEICAM-9903) Phase III Study
GEICAM
–
